Casa Minerals Inc. Provides Update on the 2023 Congress Gold Mine Exploration and Drilling Program
Vancouver, BC, Mar 22, 2023 – (ACN Newswire) – Casa Minerals Inc. (TSXV: CASA) (OTC…
Month: March 2023
ServiceNow Launches Major Platform Expansion with the Utah Release
Latest Now Platform release unveils AI-powered process mining with RPA capabilities, search, workforce optimization for…
93 Percent of Enterprise CISOs Concerned About Dark Web Threats
Report finds that US companies are more likely to gather dark web intelligence than UK…
KBRA Structured Finance Indices Now Available In HTML
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA is happy to announce that our suite of Structured Finance index reports…
Hess Selects Halliburton Well Construction Suite to Implement Digital Wells
HOUSTON–(BUSINESS WIRE)–Halliburton Company (NYSE: HAL) today announced that Hess Corporation (NYSE: HES) has selected Halliburton…
U.S. Navy Chooses Yellowbrick, Sunsets IBM Netezza
Yellowbrick selected for exemplary ease of migration, performance, and providing a pathway to the cloud…
Journey Medical Corporation to Announce Year End 2022 Financial Results on March 29, 2023
Company to host conference call to discuss financial results and provide a corporate update on…
Rakovina Therapeutics Receives Funding to Accelerate Development of Novel Cancer Therapies
VANCOUVER, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (“the…
Altamira Therapeutics’ SemaPhore Delivery Platform Shows Significant Synergis-tic Effects of ZBTB46 mRNA with PD1 Immunotherapy in Control of Tumor Growth in Animal Model
HAMILTON, BERMUDA, March 22, 2023 (GLOBE NEWSWIRE) — Preprint of results from animal study shows…
Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Patent provides intellectual property protection until December 2040 PH-HFpEF affects more than 1,600,000 North Americans, with…
Acer Therapeutics Announces Data Presented at Society for Inherited Metabolic Disorders Annual Meeting Identifying Preferred Urea Cycle Disorder Treatment Attributes
Results from survey of Urea Cycle Disorders (UCD) healthcare providers show taste and odor were…
Panbela Announces Issuance of New Patent in Japan; Patent is for Claims of a Novel Process for the Production of SBP-101
Patent developed in collaboration with Syngene International Ltd. MINNEAPOLIS, March 22, 2023 (GLOBE NEWSWIRE) —…
Inozyme Pharma Reports Full Year 2022 Financial Results and Provides Business Highlights
– Founding CEO, Axel Bolte, MSc, MBA, to retire; Douglas A. Treco, Ph.D., to succeed…
Acer Therapeutics Announces $2.675 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
NEWTON, Mass., March 22, 2023 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
Cocrystal Pharma to Highlights Progress with Its Antiviral Portfolio at the Virtual Investor Summit on March 29, 2023
BOTHELL, Wash., March 22, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that…
Promise of BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Article
VANCOUVER, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
IMUNON Presents PLACCINE Data at Vaccine Technology Summit 2023
Chief Science Officer describes compelling preclinical data supporting continued development of PLACCINE as a differentiated,…
PepGen Presents Clinical and Nonclinical Data at the 2023 Annual Muscular Dystrophy Association Clinical and Scientific Conference
– In NHP, four monthly doses of 20 mg/kg of PGN-EDO51 resulted in 34.9% exon…
VYNE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammation Disease Virtual Conference
BRIDGEWATER, N.J., March 22, 2023 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
LifeMD, Inc. Announces Closing of New $40 Million Credit Facility
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) — LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient…